Global Xerostomia Therapeutics Market By Product Type (Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs and Salivary Pen), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Application (Over The Counter (OTC) and Prescription), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Xerostomia Therapeutics Market
The xerostomia therapeutics market is substantially rising over the years. Based on the current market analysis, the global xerostomia therapeutics market is expected to exhibit a market value of USD 899.4 million and a CAGR of 3.7% for the forecast period of 2021-2028.
Xerostomia is a condition of dry mouth. It is a condition wherein the salivary glands lose their capacity to produce the desired amount of saliva in the mouth. But this isn’t the sole reason. Xerostomia may occur even in cases of not in taking required fluids, sleeping with mouth open, exposing the body against hot weather for a long time, medication side effects etc. Conditions like diabetes and HIV aids can have an impact on the salivary glands. Thus, this can also lead to xerostomia. Menopause is another reason in women that can lead to xerostomia.
Increasing adoption of chemotherapy and radio therapy in the cancer treatment process can damage the salivary glands. Thus, this has become a leading reason for individuals demanding xerostomia therapeutics. Rise in the patients with diabetes across the globe impact the salivary glands. Also, consuming medicines can have a range of side effects wherein one of them is dry mouth. Thus, people depending more and more and medicines are in a way contributing to the growth of the xerostomia therapeutics market. Rising resourcefulness and awareness of the same is also promoting the growth of the market.
On the flip side, Finger-prick Autologous Blood treatment can prove to be a restraint in the growth of this market. Finger-prick Autologous Blood (FAB) is an emerging treatment process that is regarded as a better and novel alternative to treat and tackle dry mouth. However, low level of awareness about the same in underdeveloped countries too is hampering the market for the forecast period mentioned above.
This xerostomia therapeutics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on xerostomia therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Xerostomia Therapeutics Market Scope and Market Size
The scope of xerostomia therapeutics market extends to different segments namely product type, distribution channels and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the xerostomia therapeutics market is segmented into artificial saliva, dentifrices, salivary stimulants, saliva substitutes, drugs and salivary pen.
- The market is also segmented into hospital pharmacies, retail pharmacies and online pharmacies on the basis of distribution channel.
- On the basis of application, the xerostomia therapeutics market is segmented into over the counter(OTC) and prescription.
Xerostomia Therapeutics Market Country Level Analysis
Xerostomia therapeutics market is analysed and market size insights and trends are provided by country, product type, distribution channels and application as referenced above.
The countries covered in the xerostomia therapeutics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region dominates the xerostomia therapeutics market. It is expected to follow the similar growth trends for the forecast period. This is because of the prevalence of high number of patients in the region suffering from dry mouth related diseases coupled with HIV. However, Asia-Pacific region will witness the highest growth rate for this period due to rising awareness in the developing countries and increasing health expenditure. Also, there number of patients with diabetes is significantly rising thus, acting as a market driving factor.
The country section of the xerostomia therapeutics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Xerostomia Therapeutics Market Share Analysis
Xerostomia therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to xerostomia therapeutics market.
The major players covered in the xerostomia therapeutics market report are Acacia Pharma Group Plc, Church & Dwight Co., Inc., GlaxoSmithKline plc., Hikma Pharmaceuticals PLC, LUPIN., OraCoat, Parnell Pharmaceuticals, Inc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Synedgen, EUSA Pharma, Forward Science., Mission Pharmacal Company., Eisai Co., Ltd., Saliwell Ltd., Dentaid., Bausch Health Companies Inc., Deepar Pharmaceuticals Pvt.Ltd., Pharmakon Health & Beauty Care Private Limited, and Jiana Lifescience. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-